SOPH Stock Summary and Trading Ideas (Sophia Genetics SA - | NASDAQ:SOPH)

Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.

Sophia Genetics SA - trades on the NASDAQ stock market under the symbol SOPH.

As of September 14, 2026, SOPH stock price declined to $7.86 with 301,095 million shares trading.

SOPH has a beta of 1.20, meaning it tends to be more sensitive to market movements. SOPH has a correlation of 0.06 to the broad based SPY ETF.

SOPH has a market cap of $659.42 million. This is considered a Small Cap stock.

Last quarter Sophia Genetics SA - reported $23 million in Revenue and -$.30 earnings per share. This beat revenue expectation by $2 million and missed earnings estimates by -$.08.

In the last 3 years, SOPH traded as high as $8.98 and as low as $2.30.

The top ETF exchange traded funds that SOPH belongs to (by Net Assets): ONEQ, MEDI, GNMX.

SOPH has outperformed the market in the last year with a return of +145.6%, while the SPY ETF gained +16.8%. In the last 3 month period, SOPH beat the market returning +51.2%, while SPY returned +3.4%. However, in the most recent 2 weeks SOPH has underperformed the stock market by returning -3.4%, while SPY returned -1.1%.

SOPH support price is $7.54 and resistance is $8.20 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that SOPH shares will trade within this expected range on the day.